Skip to main content

3 Result(s)

within Article Remove this filter Luigi Dogliotti Remove this filter Medicine/Public Health, general Remove this filter

and

  1. Article

    Open Access

    Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study

    We assessed the activity and toxicity of the XELBEVOCT regimen in patients with metastatic well-to-moderately differentiated neuroendocrine neoplasms (WMD-NEN). Ancillary studies evaluated hypertension, protei...

    Alfredo Berruti, Nicola Fazio, Anna Ferrero, Maria Pia Brizzi, Marco Volante… in BMC Cancer (2014)

    Download PDF (374 KB) View Article

  2. Article

    Open Access

    Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network

    Well-differentiated neuroendocrine carcinomas are highly vascularized and may be sensitive to drugs administered on a metronomic schedule that has shown antiangiogenic properties. A phase II study was designed...

    Maria P Brizzi, Alfredo Berruti, Anna Ferrero, Enrica Milanesi, Marco Volante… in BMC Cancer (2009)

    Download PDF (329 KB) View Article

  3. No Access

    Article

    Il trattamento del carcinoma del surrene

    Il trattamento di elezione nei pazienti affetti da carcinoma del cortico-surrene (ACC) è rappresentato dalla chirurgia che ha un impatto favorevole sulla sopravvivenza globale. La diagnosi di ACC è tuttavia ra...

    Dott.ssa Paola Sperone, Alfredo Berruti, Luigi Dogliotti in L’Endocrinologo (2007)